5AM Venture Management

5AM Venture Management as of June 30, 2024

Portfolio Holdings for 5AM Venture Management

5AM Venture Management holds 28 positions in its portfolio as reported in the June 2024 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Skye Bioscience Com New (SKYE) 18.2 $82M 10M 8.01
Entrada Therapeutics (TRDA) 14.1 $63M 4.4M 14.25
Enliven Therapeutics (ELVN) 13.6 $61M 2.6M 23.37
Dianthus Therapeutics (DNTH) 7.1 $32M 1.2M 25.88
Celldex Therapeutics Com New (CLDX) 4.1 $18M 497k 37.01
Biohaven (BHVN) 3.6 $16M 470k 34.71
Tyra Biosciences (TYRA) 3.4 $15M 939k 15.99
Pharvaris N V (PHVS) 3.4 $15M 798k 18.80
Praxis Precision Medicines I Com New (PRAX) 3.1 $14M 340k 41.36
Erasca (ERAS) 2.9 $13M 5.4M 2.36
Viking Therapeutics (VKTX) 2.8 $13M 238k 53.01
Moonlake Immunotherapeutics Class A Ord (MLTX) 2.8 $12M 282k 43.97
Centessa Pharmaceuticals Sponsored Ads (CNTA) 2.5 $11M 1.2M 9.03
Tectonic Therapeutic (TECX) 2.4 $11M 647k 16.47
Miragen Therapeutics (VRDN) 2.1 $9.6M 737k 13.01
Silence Therapeutics Ads (SLN) 2.0 $9.0M 476k 19.00
Anaptysbio Inc Common (ANAB) 2.0 $9.0M 358k 25.06
Gh Research Ordinary Shares (GHRS) 1.5 $6.7M 573k 11.66
Cogent Biosciences (COGT) 1.5 $6.7M 790k 8.43
Vor Biopharma (VOR) 1.4 $6.4M 6.4M 1.00
Scpharmaceuticals (SCPH) 1.2 $5.2M 1.2M 4.35
Rallybio Corp (RLYB) 1.1 $4.9M 3.6M 1.34
Q32 Bio (QTTB) 1.0 $4.5M 252k 17.95
Adverum Biotechnologies Com New (ADVM) 0.8 $3.7M 542k 6.86
Mersana Therapeutics (MRSN) 0.6 $2.6M 1.3M 2.01
Zentalis Pharmaceuticals (ZNTL) 0.4 $2.0M 490k 4.09
Cidara Therapeutics (CDTX) 0.2 $677k 57k 11.94
Eyepoint Pharmaceuticals Com New (EYPT) 0.1 $435k 50k 8.70